MENU
+Compare
UPC
Stock ticker: NASDAQ
AS OF
Oct 17 closing price
Price
$5.23
Change
-$0.22 (-4.04%)
Capitalization
2.95M

UPC Universe Pharmaceuticals Inc Forecast, Technical & Fundamental Analysis

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being... Show more

UPC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for UPC with price predictions
Oct 17, 2025

UPC's RSI Oscillator recovers from overbought zone

The 10-day RSI Indicator for UPC moved out of overbought territory on October 09, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 15 instances where the indicator moved out of the overbought zone. In of the 15 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for UPC turned negative on October 17, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UPC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

UPC broke above its upper Bollinger Band on October 07, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +9 3-day Advance, the price is estimated to grow further. Considering data from situations where UPC advanced for three days, in of 188 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 112 cases where UPC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. UPC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.053) is normal, around the industry mean (17.681). P/E Ratio (0.000) is within average values for comparable stocks, (72.923). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.078). UPC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (0.050) is also within normal values, averaging (46.505).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UPC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
UPC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
265 Jingjiu Avenue
Phone
+86 7968403309
Employees
225
Web
http://www.universe-pharmacy.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HNNA10.070.02
+0.17%
Hennessy Advisors
KN23.44-0.13
-0.55%
KNOWLES Corp
HII280.02-2.64
-0.93%
Huntington Ingalls Industries
WRN2.16-0.31
-12.55%
Western Copper and Gold Corp
NIVF1.23-0.80
-39.26%
NewGenIvf Group Limited

UPC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, UPC has been loosely correlated with BIOA. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if UPC jumps, then BIOA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UPC
1D Price
Change %
UPC100%
-4.04%
BIOA - UPC
43%
Loosely correlated
+1.37%
DRRX - UPC
27%
Poorly correlated
N/A
TXMD - UPC
22%
Poorly correlated
+19.62%
CRON - UPC
13%
Poorly correlated
+0.40%
ASRT - UPC
13%
Poorly correlated
-2.90%
More

Groups containing UPC

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UPC
1D Price
Change %
UPC100%
-4.04%
Pharmaceuticals: Generic
industry (219 stocks)
27%
Poorly correlated
-0.27%